By putting our cutting-edge research to use in clinical studies and novel technologies, we collaborate to advance scientific understanding. In partnership, we can co-develop innovations that take us all further, faster.
The Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø Division of Psychiatry, part of Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø Brain Sciences, is working with startup Tend VR. Together, we are exploring how technology could help reach more people living with anxiety and depression.
The Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø and Eisai partnership seeks to discover novel therapeutics for neurological diseases. The first drug candidate to result from their joint research, E2814, has been selected for a new trial.